Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
17 Cards in this Set
- Front
- Back
|
Atropine Sulfate Class |
Anticholinergic agent, Antidote, Antispasmodic agent, Antimuscarinic.
|
|
|
Atropine Sulfate M.O.A. |
CV: Increased heart rate; increased conduction velocity; increased force of contraction; increased cardiac output. Resp: Decreased mucus production; increased bronchial smooth muscle relaxation (bronchodilation) GI: Decreased GI secretion and motility GU: Decreased urinary bladder tone Misc: Mydriasis (pupillary dilation); decreased sweat production |
|
|
Atropine Sulfate Indications |
- Symptomatic bradycardia - Acetylcholinesterase inhibitor poisoning (organophosphate, carbamate cholinergic poisoning) |
|
|
Atropine Sulfate Adult Dose
|
- Symptomatic Bradycardia : IV/IO -- 0.5mg every 5 minutes. Max total dose of 3mg. - Organophosphate or carbamate poisoning : --- IV/IO - 1-5mg. Dose should be doubled every 5 min until signs of muscarinic excess abate --- IV infusion - 0.5-1mg/hr |
|
|
Atropine Sulfate Bonus Answers
|
Onset: 1 min Peak: IV-- 2-5min IM-- 30min Duration: 1/2 life --2-3 hours Drug Box: 3 (1mg/10ml) prefilled syringes Optional-- 1(8mg/20ml) multidose vial |
|
|
Atropine Sulfate Special Notes |
-Administering too small doses or too slowly may result in paradoxical bradycardia -Signs and symptoms of cholinergic/organophosphate poisoning: excess salivation, lacrimation, urination, defecation, bradycardia, coma -Patients that describe their glaucoma as painful probably have acute narrow angle glaucoma |
|
|
Dopamine Class |
Sympathomimetic |
|
|
Dopamine M.O.A. |
-1-2mcg/kg/min - Cerebral, renal, and mesenteric vasodilation -2-10mcg/kg/min - Beta 1 stimulation is primary effect -10-20mcg/kg/min - alpha stimulation is primary effect --(renal, mesenteric, peripheral arterial and venous vasoconstriction (increased SVR), increased pulmonary vascular resistance, and increased preload) - >20mcg/kg/min - hemodynamic effects similar to norepinephrine; May increase HR and O2 demand to undesirable limits. |
|
|
Dopamine Indications |
-Symptomatic bradycardia -Non-hypovolemic hypotension/shock (cardiogenic or septic shock AFTER fluid administration; assess breath sounds first) |
|
|
Dopamine Adult Dose |
Preparation: (if premixed not carried) Add 400mg to 250ml NS or D5W = 1600mcg/ml Bradycardia: Start at 5mcg/kg/min IV infusion Shock: Cardiogenic or Septic (non-hypovolemic) -- BP < 70 systolic: Start at 5mcg/kg/min IV infusion -- BP >70 systolic: Start at 2.5mcg/kg/min IV infusion |
|
|
Dopamine Bonus Answers |
Onset: Almost immediate Peak: 5-10 min Duration: Effects cease almost immediately when infusion is shut off Drug Box: 400mg |
|
|
Dopamine Special Notes |
-Always monitor drip rate, never run "wide open" -An infusion pump is required for interfacility transports |
|
|
Phenylephrine Nasal Spray 0.5% (Neo-synephrine) Class |
Topical vasoconstrictor |
|
|
Phenylephrine Nasal Spray 0.5% (Neo-synephrine) M.O.A. |
-Stimulates alpha receptors in the blood vessels of the nasal mucosa |
|
|
Phenylephrine Nasal Spray 0.5% (Neo-synephrine) Indications |
-Facilitation of nasotracheal intubation |
|
|
Phenylephrine Nasal Spray 0.5% (Neo-synephrine) Adult Dose |
-2-4 sprays in each nostril before attempting tube insertion |
|
|
Phenylephrine Nasal Spray 0.5% (Neo-synephrine) Bonus Answers |
Onset: Seconds Peak: 30 min Duration: 30 min - 4 hours Drug box: Optional 1 bottle |
